Narayana Hrudayalaya profit and loss

Latest FY26

Revenue: ₹7,896cr+44.0% on FY25
EBITDA: ₹1,617cr+26.7% on FY25
Net profit: ₹806cr+1.9% on FY25
EPS: ₹39.67+2.0% on FY25

₹ crore except per share

Tap a line for its trend	Last 12Mto Jun 2026	FY26Mar 2026	FY25Mar 2025	FY24Mar 2024	FY23Mar 2023	FY22 and earlierAlpha Plus

Expenses
	9,072	7,896	5,483	5,018	4,525	FY22 and earlierEvery year the company has filed comes with Alpha Plus.
	112	100	92.0	75.2	65.4
	9,184	7,996	5,575	5,093	4,590
	1,775	1,560	1,141	1,112	1,012
	−50.7	−44.3	−4.5	−38.4	−11.1
	2,232	1,803	1,093	1,004	879
	285	244	146	96.9	69.5
	520	448	278	242	210
	3,366	2,960	1,977	1,788	1,679
	8,128	6,971	4,631	4,205	3,838
	1,749	1,617	1,276	1,152	966
	1,230	1,169	998	910	756
Profit
	1,056	1,025	944	889	752
	−51.0	−51.0	−8.4	0.0	−0.2
	1,005	974	936	889	752
	198	177	130	138	140
	−21.5	−18.2	15.9	−38.7	4.5
	177	158	146	98.9	145
	−7.0	−5.6	0.0	0.0	0.0
	817	806	791	790	607
	822	810	790	790	607
	−5.1	−4.5	0.8	0.0	0.0
	183	197	33.8	13.8	56.7
	999	1,003	824	803	663
	816	806	790	789	606
	0.4	0.4	0.5	0.4	0.3
Per share
	₹40.18	₹39.67	₹38.90	₹38.86	₹29.85
	₹40.18	₹39.67	₹38.90	₹38.86	₹29.85
Revenue detail — as filed
	—	0.0	0.0	0.0	0.2
Continuing & discontinued operations
	−4.4	−3.7	1.5	0.0	0.0
	0.7	0.8	0.7	0.0	0.0
Other comprehensive income — detail
	183	197	33.8	—	—
	−8.8	−1.4	−5.3	−3.3	−6.1
	−0.7	0.3	−1.6	—	—
	—	—	—	−0.8	−2.0
	191	198	37.4	16.1	61.6
	−0.0	0.0	−0.0	—	—
	—	—	—	−0.1	0.9
	999	1,002	824	803	663
	0.4	0.4	0.5	0.4	0.3
Per share — as-filed variants
	₹40.43	₹39.89	₹38.86	₹38.86	₹29.85
	₹40.43	₹39.89	₹38.86	₹38.86	₹29.85
	−₹0.25	−₹0.22	₹0.04	₹0.00	₹0.00
	−₹0.25	−₹0.22	₹0.04	₹0.00	₹0.00
Derived — gross profit (revenue − materials − purchases − Δ inventories)
	7,348	6,380	4,347	3,944	3,524
	81.0%	80.8%	79.3%	78.6%	77.9%
Adjusted (ex-exceptional items) — derived
	1,056	1,025	944	889	752
	−51.0	−51.0	−8.4	0.0	−0.2
	859	849	798	790	607
	₹42.25	₹41.77	₹39.25	₹38.86	₹29.86

Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

alphave

NH₹1,714.50

Narayana Hrudayalaya Ltd.

· Pharma & Health

Annual Quarterly₹ CrorePeersAPOLLOHOSP MAXHEALTH FORTIS NEULANDLAB NATCOPHARM LALPATHLAB SAILIFE COHANCEMcap ₹35,038 Cr

View

In ₹ Crore except Per Share 12 Months Ending	FY23 31/03/2023	FY24 31/03/2024	FY25 31/03/2025	FY26 31/03/2026	Last 12M 30/06/2026
Revenue from Operations	4,524.8	5,018.2	5,483.0	7,896.0	9,072.4
Other Income	65.4	75.2	92.0	100.2	111.9
Total Income	4,590.2	5,093.4	5,575.0	7,996.3	9,184.3
Expenses
+ Purchases of Stock-in-Trade	1,012.3	1,112.3	1,140.9	1,560.4	1,775.3
+ Changes in Inventories	-11.1	-38.4	-4.5	-44.3	-50.7
+ Employee Benefit Expense	879.2	1,004.3	1,092.7	1,803.0	2,232.3
+ Finance Costs	69.5	96.9	146.4	243.7	285.4
+ Depreciation & Amortisation	210.0	242.1	278.1	447.8	519.6
+ Other Expenses	1,678.6	1,787.7	1,977.5	2,960.3	3,366.1
Total Expenses	3,838.4	4,204.9	4,631.1	6,970.9	8,127.9
EBITDA	965.8	1,152.4	1,276.4	1,616.7	1,749.4
EBIT	755.8	910.2	998.3	1,168.9	1,229.8
Profit
PBT before Exceptional Items	751.8	888.5	943.9	1,025.3	1,056.4
+ Exceptional Items	-0.2	0.0	-8.4	-51.0	-51.0
Pretax Income	751.6	888.5	935.5	974.4	1,005.4
+ Current Tax	140.5	137.6	129.8	176.6	198.1
+ Deferred Tax	4.5	-38.7	15.9	-18.2	-21.5
Tax Expense	145.0	98.9	145.7	158.4	176.7
+ Net Movement in Regulatory Deferral Balances	0.0	0.0	0.0	-5.6	-7.0
Net Income	606.6	789.6	790.6	806.0	816.5
+ Net Income — Continuing Ops	606.6	789.6	789.8	810.5	821.7
+ Net Income — Discontinued Ops	0.0	0.0	0.8	-4.5	-5.1
+ Other Comprehensive Income	56.7	13.8	33.8	196.7	182.9
Total Comprehensive Income	663.2	803.4	824.4	1,002.7	999.5
Net Income to Common	606.2	789.3	790.2	805.6	816.1
Minority Interest	0.3	0.4	0.5	0.4	0.4
Per Share
Basic EPS	29.85	38.86	38.90	39.67	40.18
Diluted EPS	29.85	38.86	38.90	39.67	40.18
Revenue Detail — as filed
+ Share of P&L — Partnership Firms / LLPs	0.2	0.0	0.0	0.0	—
Continuing & Discontinued Operations
+ Discontinued Operations — before Tax	0.0	0.0	1.5	-3.7	-4.4
+ Tax — Discontinued Operations	0.0	0.0	0.7	0.8	0.7
Other Comprehensive Income — detail
+ Other Comprehensive Income	—	—	33.8	196.7	182.9
+ Items NOT to be Reclassified to P&L	-6.1	-3.3	-5.3	-1.4	-8.8
+ Tax on Items NOT to be Reclassified	—	—	-1.6	0.3	-0.7
+ Tax on Items NOT to be Reclassified — alt tag	-2.0	-0.8	—	—	—
+ Items to be Reclassified to P&L	61.6	16.1	37.4	198.4	191.1
+ Tax on Items to be Reclassified	—	—	-0.0	0.0	-0.0
+ Tax on Items to be Reclassified — alt tag	0.9	-0.1	—	—	—
Comprehensive Income — Owners of Parent	662.9	803.0	823.9	1,002.3	999.1
Comprehensive Income — Non-controlling Interests	0.3	0.4	0.5	0.4	0.4
Per Share — as-filed variants
Basic EPS — Continuing Operations	29.85	38.86	38.86	39.89	40.43
Diluted EPS — Continuing Operations	29.85	38.86	38.86	39.89	40.43
Basic EPS — Discontinued Operations	0.00	0.00	0.04	-0.22	-0.25
Diluted EPS — Discontinued Operations	0.00	0.00	0.04	-0.22	-0.25
Derived — Gross Profit (Revenue − Materials − Purchases − Δ Inventories)
Gross Profit	3,523.6	3,944.3	4,346.6	6,379.9	7,347.8
Gross Margin %	77.87	78.60	79.27	80.80	80.99
Adjusted (ex-Exceptional Items) — derived
Pretax Income (Adjusted, as filed)	751.8	888.5	943.9	1,025.3	1,056.4
− Exceptional Items (reconciliation)	-0.2	0.0	-8.4	-51.0	-51.0
Net Income Adj (tax-effected)	606.7	789.6	797.7	848.7	858.5
EPS Adj	29.86	38.86	39.25	41.77	42.25
Other Filed Concepts — mapped but not yet placed in the schedule
Face Value	10.00	10.00	10.00	10.00	10.00
Filed Debt Equity	0.00	1.00	0.67	1.29	1.24
Filed Dscr	0.00	3.00	2.51	2.36	2.23
Filed Iscr	0.00	10.00	7.39	4.97	4.00
Paid Up Equity Capital	204.4	204.4	204.4	204.4	204.4

As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.